Skip to main content

Researchers find a way to create a renewable supply of cancer-fighting T cells

Researchers at the University of California, Los Angeles have made a major advance in the battle against cancer by showing that it’s possible to create mature T cells with important cancer-killing receptors from pluripotent stem cells.

This was achieved by using structures called artificial thymic organoids, which mimic the environment of the thymus, referring to the organ in which T cells develop from blood stem cells.

Recommended Videos

“Using living T cells to kill cancer cells is one of the most exciting areas of cancer treatment,” Christopher Seet, a clinical instructor in the David Geffen School of Medicine at UCLA, told Digital Trends. “The idea here would be to use self-renewing pluripotent stem cells to make unlimited numbers of T cells in the lab, which could be used directly in patients. With certain tweaks, pluripotent stem cells can be genetically engineered to make T cells that would work in any individual. [This] could make T cell immunotherapies cheaper and more widely available. Currently, T cell therapies use a patient’s own T cells and it takes time and great expense to genetically engineer these T cells and give them back to the patient. In some cases, patients may not qualify if they’re too sick, don’t have enough T cells, or the cell quality is not good enough. Faster and cheaper ‘off-the-shelf’ approaches to T cell therapies are badly needed to bring these treatments to more patients.”

This “off-the-shelf” approach could ultimately work to make T cell therapies more accessible, more affordable, and — perhaps most importantly — more effective. There’s still a way to go until this work rolls out to patients, but it is extremely promising.

“Our next goal is to engineer the pluripotent stem cells to make T cells that are suited for treating any individual,” Seet continued. “To do this we need to make sure that the T cells we make are not rejected by a patient’s immune system, and also specifically attack a patient’s tumor cells and not the rest of their body. We can achieve this by engineering these traits in the stem cells, and indeed our goal is to make T cells that not only can be given to any individual, but may function better than T cells from the blood.”

A paper describing the work was recently published in the journal Cell Stem Cell. Other researchers on the work included Gay Crooks and Amélie Montel-Hagen.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Range Rover’s first electric SUV has 48,000 pre-orders
Land Rover Range Rover Velar SVAutobiography Dynamic Edition

Range Rover, the brand made famous for its British-styled, luxury, all-terrain SUVs, is keen to show it means business about going electric.

And, according to the most recent investor presentation by parent company JLR, that’s all because Range Rover fans are showing the way. Not only was demand for Range Rover’s hybrid vehicles up 29% in the last six months, but customers are buying hybrids “as a stepping stone towards battery electric vehicles,” the company says.

Read more
BYD’s cheap EVs might remain out of Canada too
BYD Han

With Chinese-made electric vehicles facing stiff tariffs in both Europe and America, a stirring question for EV drivers has started to arise: Can the race to make EVs more affordable continue if the world leader is kept out of the race?

China’s BYD, recognized as a global leader in terms of affordability, had to backtrack on plans to reach the U.S. market after the Biden administration in May imposed 100% tariffs on EVs made in China.

Read more
Tesla posts exaggerate self-driving capacity, safety regulators say
Beta of Tesla's FSD in a car.

The National Highway Traffic Safety Administration (NHTSA) is concerned that Tesla’s use of social media and its website makes false promises about the automaker’s full-self driving (FSD) software.
The warning dates back from May, but was made public in an email to Tesla released on November 8.
The NHTSA opened an investigation in October into 2.4 million Tesla vehicles equipped with the FSD software, following three reported collisions and a fatal crash. The investigation centers on FSD’s ability to perform in “relatively common” reduced visibility conditions, such as sun glare, fog, and airborne dust.
In these instances, it appears that “the driver may not be aware that he or she is responsible” to make appropriate operational selections, or “fully understand” the nuances of the system, NHTSA said.
Meanwhile, “Tesla’s X (Twitter) account has reposted or endorsed postings that exhibit disengaged driver behavior,” Gregory Magno, the NHTSA’s vehicle defects chief investigator, wrote to Tesla in an email.
The postings, which included reposted YouTube videos, may encourage viewers to see FSD-supervised as a “Robotaxi” instead of a partially automated, driver-assist system that requires “persistent attention and intermittent intervention by the driver,” Magno said.
In one of a number of Tesla posts on X, the social media platform owned by Tesla CEO Elon Musk, a driver was seen using FSD to reach a hospital while undergoing a heart attack. In another post, a driver said he had used FSD for a 50-minute ride home. Meanwhile, third-party comments on the posts promoted the advantages of using FSD while under the influence of alcohol or when tired, NHTSA said.
Tesla’s official website also promotes conflicting messaging on the capabilities of the FSD software, the regulator said.
NHTSA has requested that Tesla revisit its communications to ensure its messaging remains consistent with FSD’s approved instructions, namely that the software provides only a driver assist/support system requiring drivers to remain vigilant and maintain constant readiness to intervene in driving.
Tesla last month unveiled the Cybercab, an autonomous-driving EV with no steering wheel or pedals. The vehicle has been promoted as a robotaxi, a self-driving vehicle operated as part of a ride-paying service, such as the one already offered by Alphabet-owned Waymo.
But Tesla’s self-driving technology has remained under the scrutiny of regulators. FSD relies on multiple onboard cameras to feed machine-learning models that, in turn, help the car make decisions based on what it sees.
Meanwhile, Waymo’s technology relies on premapped roads, sensors, cameras, radar, and lidar (a laser-light radar), which might be very costly, but has met the approval of safety regulators.

Read more